http://en.ascentagepharma.com/
A Leader in the Design of Small Molecule Therapeutics that Target Protein-Protein Interactions
Ascentage is a globally-focused clinical-stage biopharmaceutical company developing first- and best-in-class targeted therapeutics for cancers, hepatitis B & age-related diseases.
3
Distinct Apoptosis Targets
7
Product Candidates in Clinical Development
20
Years in PPI Apoptosis Research2 : GS(14)@2018-08-21 06:32:52